N-acetyl-cysteine treatment for polycystic ovary syndrome

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 3, 2004, Pages 296-297

  Kilic Okman, T ^a,b   Kucuk, M ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Homocysteine; Insulin resistance; N acetyl cysteine; Polycystic ovary syndrome; Testosterone

Indexed keywords

ACETYLCYSTEINE; HOMOCYSTEINE; HORMONE; LIPID;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 2442613019     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.03.002     Document Type: Article

References (4)

1. Atiomo W.U., El-Mahdi E.M.B., Hardiman P. Familial associations in women with polycystic ovary syndrome. Fertil Steril. 80:2003;143-145
2. Ventura P., Panini R., Pasini M.C., Scarpetta G., Salvioli G. N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion. Pharmacol Res. 40:1999;345-350
3. Rajkhowa M., Glass M.R., Rutherford A.J., Michelmore K., Balen A.H. Polycystic ovary syndrome: a risk factor for cardiovascular disease? BJOG. 107:2000;11-18
4. Fulghesu A.M., Ciampelli M., Muzj G., Belosi C., Selvaggi L., Ayala G.F. N-Acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 77:2002;1128-1135